source
- Priority review voucher prices have doubled over three years, likely to remain highRecent reporting highlights that the price of FDA priority review vouchers has roughly doubled from three years ago. The vouchers provide a shortcut that can shave about four months off the agency…
- CRISPR-based epigenetic editing shows promise in silencing hepatitis B genesA new CRISPR-based technique targets the epigenome to turn off genes that drive chronic hepatitis B infection, doing so without changing the underlying DNA sequence. Tune Therapeutics reported ear…